These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9157438)

  • 1. [New perspectives of antioxidant therapy with thiols: nacystelyn].
    Gillissen A
    Pneumologie; 1996 Dec; 50 Suppl 3():834-7. PubMed ID: 9157438
    [No Abstract]   [Full Text] [Related]  

  • 2. Nacystelyn enhances adenoviral vector-mediated gene delivery to mouse airways.
    Kushwah R; Oliver JR; Cao H; Hu J
    Gene Ther; 2007 Aug; 14(16):1243-8. PubMed ID: 17525704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liquefacients of bronchial secretion].
    Molina C; Cheminat JC; Aiache JM
    Maroc Med; 1971 Dec; 51(552):703-9. PubMed ID: 5141206
    [No Abstract]   [Full Text] [Related]  

  • 4. 50 years ago in the Journal of Pediatrics: the effect of N-acetylcysteine on the viscosity of tracheobronchial secretions in cystic fibrosis of the pancreas.
    Bear CE
    J Pediatr; 2013 Jan; 162(1):85. PubMed ID: 23260312
    [No Abstract]   [Full Text] [Related]  

  • 5. Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium.
    Ferrari S; Kitson C; Farley R; Steel R; Marriott C; Parkins DA; Scarpa M; Wainwright B; Evans MJ; Colledge WH; Geddes DM; Alton EW
    Gene Ther; 2001 Sep; 8(18):1380-6. PubMed ID: 11571577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of N-acetylcysteine in cystic fibrosis.
    Duijvestijn YC; Brand PL
    Acta Paediatr; 1999 Jan; 88(1):38-41. PubMed ID: 10090545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From mucolytic to antioxidant and liver protection: new aspects in the intensive care unit career of N-acetylcysteine.
    Kiefer P; Vogt J; Radermacher P
    Crit Care Med; 2000 Dec; 28(12):3935-6. PubMed ID: 11153640
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of N-acetylcysteine in the treatment of chronic obstructive pulmonary disease.
    van Herwaarden CL; Bast A; Dekhuijzen PN
    Neth J Med; 1995 Aug; 47(2):45-8. PubMed ID: 7566280
    [No Abstract]   [Full Text] [Related]  

  • 9. Mucolytics in cystic fibrosis.
    Henke MO; Ratjen F
    Paediatr Respir Rev; 2007 Mar; 8(1):24-9. PubMed ID: 17419975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine.
    De Lisle RC; Roach E; Jansson K
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G577-84. PubMed ID: 17615175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ambroxol].
    Akkoca Yildiz O
    Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind study of the use of acetylcysteine in patients with cystic fibrosis.
    Howatt WF; DeMuth GR
    Univ Mich Med Cent J; 1966; 32(2):82-5. PubMed ID: 5326796
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acetylcysteine in chronic obstructive pulmonary disease. Secretolytic, antioxidant or placebo?].
    Randerath W; Galetke W
    Med Monatsschr Pharm; 2003 Nov; 26(11):375-8. PubMed ID: 14652922
    [No Abstract]   [Full Text] [Related]  

  • 15. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
    Coates AL
    J Pediatr; 2001 Dec; 139(6):768-70. PubMed ID: 11743499
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cystic fibrosis. Current indications for nebulized treatments: antibiotics and DNase].
    Sardet-Frismand A
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S131-2. PubMed ID: 10088286
    [No Abstract]   [Full Text] [Related]  

  • 17. [The significance of 2-thiol-propionamido-acetic acid in the treatment of cystic fibrosis].
    Gargani GF; Vitiello B; Minicucci L; Micalizzi C; Richeri E; Romano C
    Minerva Pediatr; 1980 Nov; 32(22):1319-22. PubMed ID: 7219372
    [No Abstract]   [Full Text] [Related]  

  • 18. Plastic bronchitis as an unusual cause of mucus plugging in cystic fibrosis.
    Mateos-Corral D; Cutz E; Solomon M; Ratjen F
    Pediatr Pulmonol; 2009 Sep; 44(9):939-40. PubMed ID: 19658112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Other mucoactive agents for cystic fibrosis.
    Bye PT; Elkins MR
    Paediatr Respir Rev; 2007 Mar; 8(1):30-9. PubMed ID: 17419976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USAN Council. List No.405. New names. Dornase alfa.
    Clin Pharmacol Ther; 1998 Jun; 63(6):705. PubMed ID: 9687230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.